Alpha Cognition Stock Quote ACOG - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

5.75

Bid

5.54

Ask

6.00

Volume

17,769

5.53 Day's Range 5.8577

4.66 52 Week Range 7.00

Previous Close

5.48

Open

5.53

Last Trade

221

5.75

Last Trade Time

Average Volume (3m)

98,803

Financial Volume

$ 101,228

VWAP

5.6969

Form 8-K - Current report

Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s disease

Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition” (ACI), or the “Company”), a biopharmaceutical company developing novel therapeutics for...

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for 12,000 U.S. and...

Alpha Cognition Expands Commercial and Medical Teams with Key Leadership Hires to Support the Launch of ZUNVEYL

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies...

Form POS AM - Post-Effective amendments for registration statement

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Alpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild-to-Moderate Alzheimer’s Disease, in China

Alpha Cognition, Inc. (Nasdaq: ACOG) (“ACI” or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating...

Alpha Cognition to Present Q1 2025 ZUNVEYL (benzgalantamine) Launch Strategy Targeting the $2 Billion U.S. Alzheimer’s Long-Term Care Market During Investor Update Call

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies...

Alpha Cognition Announces Partial Exercise of Over-allotment Option

Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies...

Alpha Cognition Announces Voluntary Delisting from CSE

Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, or the “Company”), announces that in connection with the Company’s listing on the Nasdaq...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.27	-4.48504983389	6.02	6.336	5.48	40635	5.82906538	CS
4	-0.25	-4.16666666667	6	6.88	5.48	63786	6.091807	CS
12	0.08	1.41093474427	5.67	7	4.66	98803	5.87570792	CS
26	-1.25	-17.8571428571	7	7	4.66	107520	5.88657676	CS
52	-1.25	-17.8571428571	7	7	4.66	107520	5.88657676	CS
156	-1.25	-17.8571428571	7	7	4.66	107520	5.88657676	CS
260	-1.25	-17.8571428571	7	7	4.66	107520	5.88657676	CS

ACOG - Frequently Asked Questions (FAQ)

What is the current Alpha Cognition share price?

The current share price of Alpha Cognition is $ 5.75

What is the 1 year trading range for Alpha Cognition share price?

Alpha Cognition has traded in the range of $ 4.66 to $ 7.00 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MASS908 Devices Inc	$ 3.88 (95.96%)	124.48M
FRGTFreight Technologies Inc	$ 1.5606 (51.51%)	77.46M
HOTHHoth Therapeutics Inc	$ 1.23 (41.38%)	11.44M
JZXNJiuzi Holdings Inc	$ 4.29 (41.12%)	98.71k
ATLNAtlantic International Corporation	$ 4.61 (40.12%)	136.23k
AGHAureus Greenway Holdings Inc	$ 0.7621 (-64.88%)	4.51M
NKGNNKGen Biotech Inc	$ 0.1944 (-62.31%)	8.44M
TNYATenaya Therapeutics Inc	$ 0.4206 (-55.58%)	26.28M
PSTVPlus Therapeutics Inc	$ 0.302249 (-54.20%)	4.78M
PCLAPicoCELA Inc	$ 1.56 (-50.16%)	1.17M
NVDANVIDIA Corporation	$ 115.99 (1.69%)	398.59M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 11.52 (-9.08%)	192.73M
INTCIntel Corporation	$ 21.33 (-6.20%)	152.18M
BTOGBit Origin Ltd	$ 0.35 (9.61%)	135.4M
UOKAMDJM Ltd	$ 0.179799 (19.87%)	131.96M